Counterirritation by Menthol: Molecular Targets and Role in Airway Disease

薄荷醇的抗刺激作用:分子靶标及其在气道疾病中的作用

基本信息

  • 批准号:
    8022797
  • 负责人:
  • 金额:
    $ 44.64万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-01-01 至 2014-12-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Menthol, the cooling terpene derived from peppermint, is widely used for the treatment of cough, respiratory irritation and pain. As a cigarette additive menthol is especially popular with beginning smokers and in minority populations disproportionally affected by COPD, lung cancer and hypertension. It is currently unclear whether menthol contributes to these disease conditions through inhibition of the respiratory irritation response mediated by chemosensory neurons. Recently, two sensory menthol receptors were identified: TRPM8, the cold/menthol receptor, and TRPA1, a reactive irritant receptor. TRPA1 is activated by acrolein and other irritants contained in tobacco smoke. Our preliminary studies show that inhalation of menthol potently inhibits the respiratory irritation response to acrolein vapor in mice. Mice inhaling smoke from mentholated cigarettes showed higher serum levels of the nicotine metabolite, cotinine, than mice exposed to non-mentholated smoke, suggesting increased exposure to nicotine. In electrophysiological and fluorescent imaging experiments we show that menthol inhibits acrolein-activated TRPA1 channels. We hypothesize that: 1.) Menthol acts as a counterirritant, blocking sensory neuronal responses to inhaled noxious chemicals through interaction with the menthol receptors TRPA1 or TRPM8, and 2) As a tobacco additive, menthol facilitates smoke inhalation through inhibition of neuronal irritant receptor signalling, thereby accelerating nicotine dependence and lung disease. The studies proposed in this application will use physiological, biochemical, molecular and behavioral approaches to: Aim 1.) Define the roles of TRPA1 and TRPM8 in menthol-induced inhibition of acute respiratory irritation. Aim 2.) Examine the pharmacological effects of menthol and menthol-related compounds on irritant-induced activation of sensory neurons. Aim 3.) Determine the effects of menthol inhalation on smoking-induced lung inflammation and emphysema. Our proposed research will provide new insights into neuronal mechanisms of airway irritation and remodeling, and define a scientific basis for regulatory efforts targeting menthol as a tobacco additive. PUBLIC HEALTH RELEVANCE: The natural product menthol is contained in medications against cold symptoms and pain, in food and in cigarettes. This application aims to reveal how menthol reduces irritation, and if menthol causes more severe smoking-related disease. Our work may aid the government in determining whether to regulate menthol as a cigarette additive, and may reveal new treatments for cough and pain.
描述(由申请人提供):Menthol是衍生自薄荷的冷却萜烯,被广泛用于治疗咳嗽,呼吸刺激和疼痛。作为烟熏添加剂薄荷醇特别受吸烟者特别受欢迎,在受COPD,肺癌和高血压影响的少数群体中,少数群体受到了欢迎。目前尚不清楚薄荷醇是否通过抑制化学感应神经元介导的呼吸刺激反应来促进这些疾病。最近,鉴定了两个感觉薄荷醇受体:TRPM8,冷/薄荷受体和TRPA1,一种反应性刺激受体。 TRPA1被丙烯醛激活,烟草烟中包含的其他刺激性。我们的初步研究表明,吸入薄荷醇可有效抑制小鼠对丙烯醛蒸气的呼吸刺激反应。吸入薄荷香烟吸入烟雾的小鼠比暴露于非注射烟雾的小鼠表现出更高的尼古丁代谢产物血清代谢产物水平,这表明暴露于尼古丁。在电生理和荧光成像实验中,我们表明薄荷醇抑制丙烯醛激活的TRPA1通道。 We hypothesize that: 1.) Menthol acts as a counterirritant, blocking sensory neuronal responses to inhaled noxious chemicals through interaction with the menthol receptors TRPA1 or TRPM8, and 2) As a tobacco additive, menthol facilitates smoke inhalation through inhibition of neuronal irritant receptor signalling, thereby accelerating nicotine dependence and lung 疾病。本应用中提出的研究将使用生理,生化,分子和行为方法来:AIM 1.)定义TRPA1和TRPM8在薄荷醇诱导的急性呼吸刺激抑制中的作用。目标2.)检查薄荷醇和薄荷醇相关化合物对刺激性诱导的感觉神经元激活的药理作用。目标3.)确定薄荷吸入对吸烟引起的肺部炎症和肺气肿的影响。我们提出的研究将为气道刺激和重塑的神经元机制提供新的见解,并为针对薄荷醇作为烟草添加剂的监管工作定义了科学基础。 公共卫生相关性:天然产物薄荷醇包含在防寒和疼痛,食物和香烟中的药物中。该应用旨在揭示薄荷醇如何减少刺激,以及薄荷醇是否引起更严重的吸烟相关疾病。我们的工作可能有助于政府确定是否将薄荷醇调节为香烟添加剂,并可能揭示新的咳嗽和疼痛治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SVEN-ERIC JORDT其他文献

SVEN-ERIC JORDT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SVEN-ERIC JORDT', 18)}}的其他基金

Nicotine Pouches: Chemical Composition, Toxicity and Behavioral Effects of a New Tobacco Product Category
尼古丁袋:新型烟草产品类别的化学成分、毒性和行为影响
  • 批准号:
    10673370
  • 财政年份:
    2022
  • 资助金额:
    $ 44.64万
  • 项目类别:
Molecular Core
分子核心
  • 批准号:
    9703532
  • 财政年份:
    2020
  • 资助金额:
    $ 44.64万
  • 项目类别:
Anesthetic and synthetic cooling flavors in E-cigarettes: Chemistry and respiratory effects modulating nicotine intake
电子烟中的麻醉剂和合成清凉香料:调节尼古丁摄入量的化学和呼吸效应
  • 批准号:
    9982329
  • 财政年份:
    2018
  • 资助金额:
    $ 44.64万
  • 项目类别:
Mechanisms of Itch in Poison Ivy-Induced Allergic Contact Dermatitis
毒藤引起的过敏性接触性皮炎的瘙痒机制
  • 批准号:
    9164682
  • 财政年份:
    2016
  • 资助金额:
    $ 44.64万
  • 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
  • 批准号:
    8900466
  • 财政年份:
    2012
  • 资助金额:
    $ 44.64万
  • 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
  • 批准号:
    8416589
  • 财政年份:
    2012
  • 资助金额:
    $ 44.64万
  • 项目类别:
Accelerating Inflammation Resolution to CounterACT Chemical Injury
加速炎症消退以对抗化学损伤
  • 批准号:
    8547809
  • 财政年份:
    2012
  • 资助金额:
    $ 44.64万
  • 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
  • 批准号:
    8209236
  • 财政年份:
    2011
  • 资助金额:
    $ 44.64万
  • 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
  • 批准号:
    8605272
  • 财政年份:
    2011
  • 资助金额:
    $ 44.64万
  • 项目类别:
Counter-Irritation by Menthol: Molecular Targets and Role in Airway Disease
薄荷醇抗刺激:分子靶标及其在气道疾病中的作用
  • 批准号:
    8580913
  • 财政年份:
    2011
  • 资助金额:
    $ 44.64万
  • 项目类别:

相似国自然基金

用于急性出血控制的硅酸钙复合海绵的构建及其促凝血性能和机制研究
  • 批准号:
    32301097
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
AF9通过ARRB2-MRGPRB2介导肠固有肥大细胞活化促进重症急性胰腺炎发生MOF的研究
  • 批准号:
    82300739
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
代谢工程化MSC胞外囊泡靶向调控巨噬细胞线粒体动力学改善急性肾损伤的作用及机制研究
  • 批准号:
    32371426
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目
DUSP2介导自噬调控气管上皮细胞炎症在急性肺损伤中的机制研究
  • 批准号:
    82360379
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
超声射频信号神经回路策略模型定量肌肉脂肪化评估慢加急性肝衰竭预后
  • 批准号:
    82302221
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Early life bladder inflammatory events in female mice lead to subsequent LUTS in adulthood
雌性小鼠生命早期的膀胱炎症事件导致成年后的 LUTS
  • 批准号:
    10638866
  • 财政年份:
    2023
  • 资助金额:
    $ 44.64万
  • 项目类别:
Improving our mechanistic understanding of Electronic-cigarette, or vaping, product use-associated lung injury
提高我们对电子烟或电子烟产品使用相关肺损伤的机制理解
  • 批准号:
    10115186
  • 财政年份:
    2020
  • 资助金额:
    $ 44.64万
  • 项目类别:
Lipid metabolites can both potentiate and treat alcoholic hepatitis
脂质代谢物可以增强和治疗酒精性肝炎
  • 批准号:
    9791137
  • 财政年份:
    2018
  • 资助金额:
    $ 44.64万
  • 项目类别:
Lipid metabolites can both potentiate and treat alcoholic hepatitis
脂质代谢物可以增强和治疗酒精性肝炎
  • 批准号:
    10202388
  • 财政年份:
    2018
  • 资助金额:
    $ 44.64万
  • 项目类别:
Lipid metabolites can both potentiate and treat alcoholic hepatitis
脂质代谢物可以增强和治疗酒精性肝炎
  • 批准号:
    10441376
  • 财政年份:
    2018
  • 资助金额:
    $ 44.64万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了